Eleusis

Private psychedelics medicine company Beckley Psytech Ltd. has acquired 100% of clinical-stage life sciences company Eleusis Therapeutics Ltd., entitling the former to full developmental and commercial rights of the latter’s assets.  Eleusis CEO Shlomi Raz will become Beckley’...

CEO and founder of psychedelics company Eleusis, Shlomi Raz has extensive experience in managing companies. With a BS in Finance and a later an MA in Psychology, Raz became a vice president at JP Morgan (NYSE: JPM) and managing director at Goldman Sachs (NYSE: GS). In 2013, he founded Eleusis...

Psychedelics Legalization Gains Momentum Around The Country: Bills Introduced In Utah, Virginia, Kansas And Missouri A wave of psychedelics legislation continues to sweep across the country. In Virginia, two very similar proposals were introduced simultaneously in the House and Senate by Del. Dawn...

British psychedelics company Eleusis will go public via a merger with Silver Spike Acquisition Corp. II (“SPKB”) (NASDAQ: SPKB), a special purpose acquisition company sponsored by an affiliate of Silver Spike Capital. The two companies confirmed Thursday they have signed a...

This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Psilocybin Alpha. In just a couple of years, psychedelics took the world of investing by storm. What in 2019 was merely a buzzword for investors became a full-fledged industry boasting over 25...

Health Canada Considers MDMA And Psilocybin 'Special Access' Program This week, Health Canada opened a public consultation on its “proposal to restore potential access to restricted drugs through the Special Access Program (SAP).” The SAP allows healthcare professionals to...